WEHI has launched its third Reconciliation Action Plan, building on the institute’s deep commitment to broaden and strengthen reconciliation with Aboriginal and Torres Strait Islander peoples.
WEHI has launched its third Reconciliation Action Plan, building on the institute’s deep commitment to broaden and strengthen reconciliation with Aboriginal and Torres Strait Islander peoples.
Professor David Komander has been elected a Fellow of the Australian Academy of Science for his significant research contributions towards unravelling the ubiquitin system.
New research that could lead to a vaccine for patients with hard-to-treat cancers has been backed with over $900,000 in funding from the Medical Research Future Fund (MRFF).
An advanced immunotherapy treatment could hold promise for children with an inoperable type of brain cancer, according to new research.
A study of women recently diagnosed with breast cancer has found many have identifiable and well understood gene abnormalities, and yet they are excluded from subsidised genetic testing that can guide their treatment.
A world-first study exploring new ways to fight anaemia in developing nations has found a single iron infusion can significantly reduce iron deficiency in pregnant women, compared with daily tablets.
Understanding the differences in the evolution of lung cancer between smokers and non-smokers could be the key to unlocking new treatments.
A new antimalarial drug candidate, discovered through a longstanding collaboration between WEHI and global biopharmaceutical company MSD has entered Phase 1 clinical testing in healthy participants.
A landmark discovery linking iron regulation to a rare blood cancer has led to clinical trials of a potential new treatment for patients with the incurable disease.
WEHI director Professor Doug Hilton AO and researchers Professor Wai-Hong Tham and Dr Caleb Dawson have been honoured with prestigious National Health and Medical Research Council (NHMRC) Research Excellence Awards.